Baylor College of Medicine’s Human Genome Sequencing Center is increasing its fleet of 454 Genome Sequencer FLX instruments to 10 from three by year’s end, 454’s parent Roche said this week.
Stocking up on the instruments is “laying down the pathway” for large-scale resequencing projects “in the anticipation that the unreserved support [from funding agencies] will come for it,” according to Richard Gibbs, director of Baylor’s Human Genome Sequencing Center.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.